Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
Stroke and Vascular Neurology

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome

DOI: 10.1136/svn-2018-000163corr1 Published 4 July 2019
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 4 no. 2 108
DOI 
https://doi.org/10.1136/svn-2018-000163corr1
PubMed 
31338223

Print ISSN 
2059-8688
Online ISSN 
2059-8696
History 
  • Published online July 4, 2019.

Article Versions

  • Previous version (March 2, 2019 - 04:46).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Author Information

View Full Text

Article usage

Article usage: March 2019 to May 2025

AbstractFullPdf
Mar 2019838041
Apr 201925244
May 201912124
Jun 201917156
Jul 2019474518
Aug 201929299
Sep 2019414118
Oct 2019282815
Nov 201918189
Dec 201918174
Jan 202018186
Feb 202049489
Mar 202025256
Apr 202021213
May 202021223
Jun 202020209
Jul 2020272610
Aug 202011114
Sep 2020292815
Oct 202033328
Nov 2020272712
Dec 202023213
Jan 202111125
Feb 202113134
Mar 202115155
Apr 202113138
May 202121218
Jun 202118173
Jul 2021161617
Aug 2021161610
Sep 2021885
Oct 2021191923
Nov 2021313116
Dec 202111113
Jan 202215156
Feb 202212158
Mar 202219197
Apr 202221217
May 2022232312
Jun 202228287
Jul 2022181711
Aug 2022272711
Sep 2022383729
Oct 2022292913
Nov 2022171711
Dec 202217169
Jan 2023111313
Feb 202339393
Mar 202318196
Apr 20237910
May 2023131313
Jun 202316169
Jul 202316167
Aug 2023414112
Sep 202328287
Oct 202316163
Nov 202334346
Dec 202357572
Jan 202431313
Feb 202430306
Mar 2024797934
Apr 202435356
May 202437362
Jun 202453507
Jul 2024444610
Aug 202416142
Sep 202421219
Oct 2024404015
Nov 202410102
Feb 2025330
Mar 2025110
Apr 20250412
May 202501360

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 4 Issue 2 Table of Contents
Stroke and Vascular Neurology: 4 (2)
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
(Your Name) has sent you a message from Stroke and Vascular Neurology
(Your Name) thought you would like to see the Stroke and Vascular Neurology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
Stroke and Vascular Neurology Jun 2019, 4 (2) 108; DOI: 10.1136/svn-2018-000163corr1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
Stroke and Vascular Neurology Jun 2019, 4 (2) 108; DOI: 10.1136/svn-2018-000163corr1
Download PDF

Share
Correction: Intravenous tirofiban therapy for patients with capsular warning syndrome
Stroke and Vascular Neurology Jun 2019, 4 (2) 108; DOI: 10.1136/svn-2018-000163corr1
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
  • Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
  • Correction: Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS
Show more Correction

Similar Articles

 
 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • eLetters
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Recommend to librarian
  • Chinese Stroke Association

AUTHORS

  • Instructions for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2025 Chinese Stroke Association